9.00% p.a. Multi Barrier Reverse Convertible
Eli Lilly, Novo Nordisk
Valor
135618484
SIX Symbol
OKYRCH
ISIN
CH1356184841
Currency
USD
Bid (indicative)
52.51%
250'000.00
Price on
02:45
04 Jun 2025
Issue Terms
Identifiers
135618484
CH1356184841
OKYRCH
Yield Enhancement
Barrier Reverse Convertible
Callable Multi Barrier Reverse Convertible
1230
Figures
-40.74%
Parameters
Raiffeisen Switzerland B.V., Amsterdam, The Netherlands
Raiffeisen Switzerland Cooperative, St. Gallen, Switzerland
Quarterly
9.00% p.a.
Cash Settlement or Delivery of Underlying
Dirty (accrued interest included)
100%
USD 1'000.00
USD
USD 250'000.00
Listed
Yes
Life Cycle
1.5 Years
07 Jun 2024
14 Jun 2024
14 Jun 2024
24 Jun 2024
24 Jun 2024
17 Dec 2025
24 Dec 2025
Barrier
55.00%
Continuous barrier observation (american)
14 Jun 2024 - 17 Dec 2025
Yes
Product Specific Features
100.00%
Performance
Market Price Initial Fixing Level Barrier Level Strike Level Distance to Strike
Market Price
USD 750.87
Initial Fixing Level USD 878.45 Barrier Level USD 483.15 Strike Level USD 878.45 Distance to Strike -16.99%
Market Price
DKK 466.35
Initial Fixing Level DKK 991.00 Barrier Level DKK 545.05 Strike Level DKK 991.00 Distance to Strike -112.50%
Created with Highstock 2.1.10No data to displayHighcharts.com
Cannot load the chart. Please try again later
Coupons
Payment Date Amount
Payment Date24 Sep 2024 Amount2.25%
Payment Date24 Dec 2024 Amount2.25%
Payment Date24 Mar 2025 Amount2.25%
Payment Date25 Jun 2025 Amount2.25%
Payment Date24 Sep 2025 Amount2.25%
Payment Date24 Dec 2025 Amount2.25%
Early Redemption
Observation Date Redemption Amount
Observation Date17 Jun 2025 Redemption Amount100.00%
Observation Date17 Sep 2025 Redemption Amount100.00%